0001567619-21-011201.txt : 20210526 0001567619-21-011201.hdr.sgml : 20210526 20210526173037 ACCESSION NUMBER: 0001567619-21-011201 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210524 FILED AS OF DATE: 20210526 DATE AS OF CHANGE: 20210526 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: AYERS JONATHAN W CENTRAL INDEX KEY: 0001184149 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 21967601 MAIL ADDRESS: STREET 1: IDEXX LABORATORIES, INC. STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 doc1.xml FORM 4 X0306 4 2021-05-24 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001184149 AYERS JONATHAN W ONE IDEXX DRIVE WESTBROOK ME 04092 1 0 0 0 Common Stock 2021-05-24 4 M 0 5000 79.54 A 658701 D Common Stock 2021-05-24 4 S 0 5000 546.9787 D 653701 D Common Stock 2021-05-25 4 M 0 5000 79.54 A 658701 D Common Stock 2021-05-25 4 S 0 4800 552.1183 D 653901 D Common Stock 2021-05-25 4 S 0 200 553.37 D 653701 D Common Stock 10000 I by Ayers Family Trust Non-Qualified Stock Option (right-to-buy) 79.54 2021-05-24 4 M 0 5000 D 2025-02-13 Common Stock 5000 130000 D Non-Qualified Stock Option (right-to-buy) 79.54 2021-05-25 4 M 0 5000 D 2025-02-13 Common Stock 5000 125000 D Represents the weighted average price of the shares sold ranging from a low of $546.545 to a high of $547.27 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Represents the weighted average price of the shares sold ranging from a low of $552.00 to a high of $552.675 per share. The undersigned undertakes, upon a request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price. Grant of option to buy 74,316 shares of IDEXX Laboratories, Inc. common stock that became exercisable in five equal annual installments beginning on February 14, 2016 without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split. Not applicable. /s/ Lily J. Lu, Attorney-in-Fact for Jonathan W. Ayers 2021-05-26